CTX — Captor Therapeutics SA Share News
0.000.00%
Last trade - 00:00- PLN495.56m
- PLN480.87m
- PLN4.66m
Brief: Captor Therapeutics Q1 Net Loss At 11.4 Million Zlotys
Brief: Captor Therapeutics FY Net Loss At 42.0 Million Zlotys
Brief: Captor Therapeutics To Sell 800,000 Y Series Shares At 82 Zlotys/Shr
Brief: Captor Therapeutics Starts ABB Process For Up To 800,000 New Series Y Shares
Brief: Captor Therapeutics 9 Months Net Loss At 32 Million Zlotys
Brief: Captor Therapeutics Signs Deal With EISMEA For Funding Of Ct-03 Aml Trials Project
Brief: Captor Therapeutics H1 Net Loss At 20.5 Mln Zlotys
Brief: Captor Therapeutics Appoints Michal Walczak As CEO
Brief: Captor Therapeutics Q1 Net Loss At 10.7 Mln Zlotys
Brief: Captor Therapeutics Ends Dispute With Poland's National Centre For R&D
Brief: Captor Therapeutics To Refund 4.1 Mln Zlotys To Poland's National Center For R&D
Brief: Captor Therapeutics FY Net Loss At 38.4 Mln Zlotys
Brief: Captor Therapeutics EGM Resolves On Launching Incentive Programme
Brief: Captor Therapeutics Seeks EUR 7.8 Mln From EIC Accelerator For CT-03 AML Trials
Brief: Captor Therapeutics Completes Subscription Of 0.8 Mln Series T Shares
Brief: Captor Therapeutics Sets Issue Price Of T Series Shares At 40 Zlotys
Brief: Captor Therapeutics Starts ABB For Max. 0.8 Mln Shares
Brief: Captor Therapeutics 9-Month Net Loss At 29.7 Mln Zlotys
Brief: Captor Therapeutics Selects Candidate For Clinical Trial In CT-03 Project